Insulin aspart, recombinant Subcutaneous and Treprostinil Extended-Release Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Treprostinil Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: treprostinil
Brand name: Orenitram, Remodulin, Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit
Synonyms: Treprostinil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Treprostinil inhalation
- Insulin aspart, recombinant Subcutaneous-Treprostinil injection
- Insulin aspart, recombinant Subcutaneous-Treprostinil Injection Solution
- Insulin aspart, recombinant Subcutaneous-Treprostinil Oral Inhalation Solution
- Insulin aspart, recombinant Subcutaneous-Treprostinil Sodium
- Insulin aspart, recombinant Subcutaneous-Tresiba
- Treprostinil Extended-Release Tablets-Insulin degludec
- Treprostinil Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Treprostinil Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Treprostinil Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Treprostinil Extended-Release Tablets-Insulin degludec and liraglutide
- Treprostinil Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous